![]() |
市场调查报告书
商品编码
1963853
超强吸收性敷料市场-全球产业规模、份额、趋势、机会和预测:按产品类型、应用、最终用户、地区和竞争格局划分,2021-2031年Superabsorbent Dressings Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Application, By End User, By Region & Competition, 2021-2031F |
||||||
全球超吸收性敷料市场预计将从 2025 年的 2.2311 亿美元成长到 2031 年的 2.9711 亿美元,复合年增长率为 4.89%。
这些专业的创伤护理产品采用多层芯材设计,能够有效吸收并保留体液,从而有效处理中度至重度渗出液,防止皮肤浸渍。推动这一市场成长的主要因素是全球范围内需要有效液体管理以促进癒合的慢性疾病(例如压疮和静脉性腿部溃疡)发病率的不断上升。此外,全球人口老化,以及由此导致的手术量增加和与老龄化相关的皮肤脆弱性,也增加了居家照护和临床环境中对这类吸收性产品的需求。
| 市场概览 | |
|---|---|
| 预测期 | 2027-2031 |
| 市场规模:2025年 | 2.2311亿美元 |
| 市场规模:2031年 | 2.9711亿美元 |
| 复合年增长率:2026-2031年 | 4.89% |
| 成长最快的细分市场 | 慢性伤口 |
| 最大的市场 | 北美洲 |
根据国际糖尿病联盟(IDF)的数据,到2024年,全球将有约5.89亿成年人患有糖尿病。如此庞大的患者群体导致糖尿病足溃疡的发生率不断上升,并对先进的渗出液管理解决方案产生了持续的需求。然而,与传统创伤护理材料相比,先进敷料的高成本是阻碍市场成长的主要障碍。这种价格差异往往限制了它们的普及,尤其是在医疗报销预算有限的地区。
慢性伤口,尤其是静脉性腿部溃疡和糖尿病足溃疡在全球日益普遍,是吸收性敷料领域发展的主要驱动力。这些复杂的伤口通常会产生大量渗出液,而标准敷料难以有效吸收,因此,吸收性聚合物在旨在预防浸渍、隔离细菌和维持最佳湿润环境的临床通讯协定中至关重要。领先製造商的财务表现也印证了这一日益增长的临床需求。例如,根据康维德集团(Convatec Group Plc)于2024年3月发布的“2023财年报告”,该公司先进创伤护理部门的收入增长了12.0%,达到6.95亿美元,凸显了全球对有效溃疡治疗方法日益增长的需求。
同时,与老化相关的生理变化,例如细胞再生速度减慢和皮肤弹性下降,进一步增加了对先进创伤护理解决方案的需求。老年人尤其容易出现血管併发症和压疮,对医疗保健系统造成沉重负担,因此,高吸收性、长效敷料的使用日益受到重视,以减少照护时间。根据人口与社会安全研究所于2024年9月发布的《2024年世界人口资料表》,目前65岁以上人口占全球总人口的10%,约8亿。这一人口趋势正在推动行业成长,科乐普公司于2024年11月发布的《2023/24年度报告》证实了这一点,该报告显示其先进创伤护理业务板块实现了10%的内部成长。
超强吸收性敷料的高昂价格是其广泛市场推广的主要障碍,尤其与更经济的替代品(如普通棉布或纱布)相比更是如此。儘管临床证据显示这些先进产品在处理大量渗出液方面卓有成效,但其高昂的价格令面临财政紧缩的医疗采购部门却步。这种成本差异在医疗资金有限的地区尤其关键,导致决策者优先考虑预算控製而非采用高端创伤护理技术,也阻碍了以降低单位成本为首要目标的公共医疗系统对这些技术的推广应用。
这种经济障碍因柔软性的报销政策而进一步加剧,这些政策往往无法充分涵盖先进伤口护理产品的成本。根据欧洲伤口管理协会 (EWMA) 2024 年的报告,欧洲部分地区的报销方案仅涵盖先进创伤护理总成本的 60% 至 90%,剩余部分则由患者或医疗机构承担。这种部分补偿导致人们继续依赖价格较低的传统材料,直接阻碍了全球超吸收性敷料市场的成长和收入扩张。
吸收性敷料市场的一项关键发展趋势是向硅胶边缘和非侵入性黏合剂的转变,这主要源自于临床上减少医用黏合剂相关皮肤损伤(MARSI)的需求。与传统黏合剂不同,后者在移除时可能会造成损伤,尤其是在皮肤脆弱的患者中,而硅胶配方提供了一种温和的固定方式,能够牢固地粘附在干燥的皮肤上,同时易于移除且不会损伤角质层。这项技术进步提高了患者的依从性,延长了敷料的佩戴时间,从而为医疗保健机构带来了经济效益。这项转变的商业性成功体现在近期的财务报告中。 Paul Hartmann AG 于 2024 年 3 月发布的 2023 财年年度报告中显示,创伤护理业务的有机销售额增长了 5.6%,这显然归功于该公司硅胶基吸收性敷料的强劲表现。
同时,抗菌剂的加入正将这些产品从被动的液体吸收器转变为主动治疗设备,用于感染控制。在全球对抗生素抗药性日益关注的背景下,製造商正在将PHMB(次氯酸钠)、碘和银等抗菌剂添加到超吸收性敷料芯中,以主动降低敷料内的微生物附着量(微生物数量)并抑制生物膜的形成。这一趋势旨在解决慢性伤口的复杂性问题,因为简单的渗出液管理不足以应对此类伤口,使这些混合敷料成为感染控制的关键工具。市场数据也支持对生物活性解决方案的需求。根据史密斯医疗(Smith & Nephew)于2024年2月发布的“2023年第四季度及全年财务业绩”,该公司“先进伤口生物活性产品”组合在第四季度实现了12.5%的核心收入增长,凸显了感染控制疗法的快速普及。
The Global Superabsorbent Dressings Market is projected to expand from USD 223.11 Million in 2025 to USD 297.11 Million by 2031, registering a CAGR of 4.89%. These specialized wound care solutions feature a multi-layered core designed to effectively manage moderate to heavy exudate by sequestering fluid and preventing skin maceration. A primary factor fueling this market growth is the increasing global incidence of chronic conditions, such as pressure injuries and venous leg ulcers, which require efficient fluid management to facilitate healing. Additionally, the aging global population supports demand due to higher rates of surgical procedures and age-related skin fragility, necessitating these absorbent products in both home care and clinical environments.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 223.11 Million |
| Market Size 2031 | USD 297.11 Million |
| CAGR 2026-2031 | 4.89% |
| Fastest Growing Segment | Chronic Wounds |
| Largest Market | North America |
According to the International Diabetes Federation, approximately 589 million adults worldwide were living with diabetes in 2024. This substantial patient base leads to a higher prevalence of diabetic foot ulcers, creating a continuous need for advanced exudate management solutions. However, a significant barrier potentially hindering market growth is the elevated cost of these advanced dressings compared to traditional wound care materials. This price disparity often restricts their adoption, particularly in regions where healthcare reimbursement budgets are limited.
Market Driver
The increasing global prevalence of chronic wounds, specifically venous leg ulcers and diabetic foot ulcers, serves as a major driver for the superabsorbent dressings sector. Because these complex injuries frequently generate high volumes of exudate that standard dressings cannot sufficiently handle, superabsorbent polymers have become essential in clinical protocols to prevent periwound maceration, sequester bacteria, and maintain optimal moisture balance. This growing clinical necessity is underscored by the financial results of leading manufacturers; for instance, according to Convatec Group Plc in March 2024, their Advanced Wound Care division reported a 12.0% revenue increase to $695 million in their 'Annual Results 2023', highlighting the rising global demand for effective ulcer therapies.
Concurrently, the expanding geriatric population intensifies the need for sophisticated wound care solutions due to physiological changes associated with aging, such as slower cellular regeneration and reduced skin elasticity. Older adults are disproportionately prone to vascular complications and pressure injuries, creating a burden on healthcare systems that encourages the use of highly absorbent, extended-wear dressings to reduce nursing time. According to the Population Reference Bureau's '2024 World Population Data Sheet' from September 2024, individuals aged 65 and older now make up 10% of the global population, totaling roughly 800 million people. This demographic trend drives industry growth, as evidenced by Coloplast A/S, which reported a 10% organic growth rate in its Advanced Wound Care business area in their 'Annual Report 2023/24' released in November 2024.
Market Challenge
The elevated price of superabsorbent dressings poses a substantial obstacle to broad market adoption, especially when compared to economical alternatives such as standard cotton wool or gauze. Despite clinical evidence demonstrating the effectiveness of these advanced products in handling heavy exudate, their premium pricing causes hesitation among healthcare procurement departments facing strict fiscal limitations. This cost disparity becomes a critical factor in areas with finite healthcare funding, often leading decision-makers to favor immediate budget compliance over the implementation of premium wound care technologies, thereby stifling uptake in public health systems focused on reducing unit costs.
This economic barrier is exacerbated by inflexible reimbursement policies that frequently fail to fully offset the expense of advanced wound management products. According to the European Wound Management Association in 2024, reimbursement schemes in certain European regions covered only 60% to 90% of the total costs for advanced wound care, forcing patients or healthcare providers to cover the financial shortfall. Such partial coverage encourages the continued reliance on less expensive, traditional materials, which directly impedes the volume expansion and revenue growth of the global superabsorbent dressings market.
Market Trends
A significant evolution in the superabsorbent dressings market is the transition toward silicone-bordered and atraumatic adhesives, driven by the clinical need to mitigate medical adhesive-related skin injuries (MARSI). Unlike traditional adhesives that may cause trauma upon removal, particularly for patients with friable or fragile skin, silicone formulations offer gentle fixation that secures well to dry skin but releases easily without damaging the stratum corneum. This technological advancement enhances patient compliance and enables longer wear times, offering economic benefits to healthcare providers. The commercial success of this shift is reflected in recent financial reports; according to Paul Hartmann AG's 'Annual Report 2023' from March 2024, the Wound Care segment posted 5.6% organic sales growth, explicitly attributed to the strong performance of their silicone superabsorbent dressings.
Simultaneously, the incorporation of antimicrobial agents for infection control is evolving these products from passive fluid absorbers into active therapeutic devices. Amidst global concerns regarding antibiotic resistance, manufacturers are infusing superabsorbent cores with agents like PHMB, iodine, or silver to actively lower bioburden and inhibit biofilm formation within the dressing. This trend addresses the complexities of chronic wounds where simple exudate management is insufficient, positioning these hybrid dressings as crucial tools for infection control. Market data supports the demand for bioactive solutions; according to Smith+Nephew's 'Fourth Quarter and Full Year 2023 Results' from February 2024, their Advanced Wound Bioactives portfolio achieved an underlying revenue growth of 12.5% in the fourth quarter, underscoring the rapid adoption of infection-managing therapies.
Report Scope
In this report, the Global Superabsorbent Dressings Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Superabsorbent Dressings Market.
Global Superabsorbent Dressings Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: